Dezhan Healthcare Co (000813.SZ) Osake Kurssi

Dezhan Healthcare Co., Ltd. generates revenue through the development and sale of cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. The company's subsidiaries produce injections, biopharmaceuticals, and Chinese medicine preparations to optimize product structures and meet diverse market demands. Its primary market is China, where it targets consumers seeking health and wellness solutions through pharmaceutical and functional beverage offerings. The firm focuses on human life sciences research, emphasizing cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. Subsidiaries introduce production lines for multiple dosage forms, including injections, biopharmaceuticals, and Chinese medicine preparations, to enhance product variety and meet specific consumer needs within the Chinese market. Sales are driven by the domestic demand for health-focused pharmaceutical and beverage products.